How is ADHD medication started and monitored in teenagers?

A baseline review comes first

A clinician usually starts by checking whether medication is appropriate for this teen, and what needs watching before the first dose. This step is not just about symptoms. It also sets a starting point so changes can be judged properly later.

Before starting, the clinician commonly reviews the teen’s ADHD symptoms, day-to-day impairment, past treatment, other health conditions, current medications or supplements, sleep, appetite, substance use risk, and any history that could matter for safety, including heart concerns. The Canadian Paediatric Society says height, weight, blood pressure and pulse should be measured, and that parents and older children can provide baseline observations about symptoms and possible adverse effects. It also recommends goal-setting and standardized checklists to monitor response over time.

• Current symptoms at home, school and socially
• A few specific treatment goals, such as finishing homework with less prompting or fewer classroom disruptions
• Height and weight
• Blood pressure and pulse
• Sleep pattern, appetite and mood
• Other conditions that can overlap with ADHD, including anxiety or depression
• Any concerns about misuse, diversion or substance use

If a teen needs help now because of substance use, self-harm, anxiety, depression, or suicidal thoughts, call or text 9-8-8 in Canada, or call 911 in an emergency.

Starting is usually gradual

Most teens do not start at a full target dose on day one. Medication is usually started low and adjusted step by step, based on benefit and side effects rather than speed.

CADDRA’s Canadian ADHD Practice Guidelines describe titration and monitoring as a structured process. They recommend setting target outcomes, using follow-up forms or rating scales, and keeping regular contact during the titration phase. Health Canada’s Drug Product Database is the official place clinicians use to confirm which products are marketed in Canada and to access Canadian product monographs, which contain approved dosing and safety information.

Dose changes are usually based on function, not just feelings. A teen may say they feel more focused, but the clinician also wants to know whether mornings, classes, assignments, routines or driving-readiness behaviours are actually improving.

Tracking side effects needs a plan

Side-effect tracking works better when the family writes things down. In practice, the most useful notes are simple, specific and dated.

The Canadian Paediatric Society recommends standardized questionnaires and checklists during initial titration and monitoring, with information from more than one setting, including school when possible. It also recommends monitoring growth in children and youth treated with stimulant medications, and monitoring blood pressure before treatment, after dose increases and periodically for certain non-stimulant options.

• What time the medication was taken
• When benefit seemed to start and stop
• Appetite changes at breakfast, lunch and dinner
• Trouble falling asleep or staying asleep
• Headache, stomach upset, dizziness, jitteriness or feeling flat
• Mood changes, including irritability or tearfulness
• Whether the teen wanted to stop, skip or hide doses

Families do not need to solve side effects alone. If something changes suddenly, or the teen develops chest pain, fainting, severe mood change, or thoughts of self-harm, urgent medical advice is needed. If a teen needs help now because of suicidal thoughts, self-harm, substance use, anxiety or depression, call or text 9-8-8 in Canada, or call 911 in an emergency.

For a deeper look at common problems after a start, see How does ADHD medication affect appetite, growth, and sleep in teenagers?.

Parent-teen follow-up should be clear

Clear follow-up plans spell out who notices what, and when the prescriber will hear about it. Teen ADHD care often works more smoothly when the teen is treated as the main reporter of their own experience, while a parent adds observations about routines, sleep, appetite, mood and function.

This does not mean every visit looks the same. Consent and family involvement depend on the young person’s circumstances, maturity, applicable law and clinical judgment. Still, in many cases, parent input is useful early on because teens may notice internal effects while parents notice patterns over time.

• The teen tracks how they feel during class, homework, social time and evenings
• A parent tracks meals, sleep, morning routine, emotional changes and missed doses
• The school may add feedback if the family agrees and it is practical
• The prescriber reviews both benefit and side effects before each dose change
• The family is told when to check in sooner instead of waiting for the next visit

If the main question is what happens after the prescription has already been started, see How is ADHD medication monitored after I start?.

Early monitoring is often frequent

Follow-up is usually closer together at the beginning than later on. The titration period often involves brief but regular review so the dose can be adjusted safely and on purpose, not left unchanged for too long if it is clearly not helping.

CADDRA states that regular contact during titration is recommended, including by visit or other follow-up methods. The Canadian Paediatric Society also stresses that treatment response should be tracked with standardized tools and information from at least two settings. In Canada, clinicians can also use Health Canada’s Drug Product Database to check current monographs and safety updates if questions come up during monitoring.

A practical expectation for families is this: the first phase is about fine-tuning. It can take more than one follow-up to find a useful dose or to decide that a different medication class, timing plan, school support, or non-medication support is needed. Medication is one part of care, not the whole plan.